Changing spectrum of invasive candidates and its therapeutic implications

Clinical Microbiology and Infection

Volumn 7, Issue SUPPL. 2, 2001, Pages 1-7

  Denning, D W ^a  

^a NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PLACEBO; PYRROLE DERIVATIVE;

ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA; CANDIDIASIS; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG EFFICACY; DRUG UTILIZATION; FUNGICIDAL ACTIVITY; HOSPITAL PATIENT; HUMAN; INCIDENCE; INFECTION RISK; INTENSIVE CARE UNIT; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; SIDE EFFECT;

CANDIDA;

EID: 0035747120     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2001.tb00004.x     Document Type: Article

References (49)

1. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990
2. Nosocomial infections in Swiss University hospitals: A multicentre survey and review of the published experience
3. Nosocomial bloodstream infections in United States hospitals: A three-year analysis
4. Variation in rates of Candida bloodstream infection in seven surgical ICUs and six neonatal ICUs
5. The impact of candidemia on length of hospital stay, outcome, and overall cost of illness
6. The epidemiology of hematogenous candidiasis caused by different Candida species
7. Secular trends in the epidemiology of nosocomial fungal infections at a teaching hospital in Taiwan, 1981 to 1993
8. High rate of non-albicans candidemia in Brazilian tertiary care hospitals
9. Fluconazole and the changing epidemiology of candidemia
10. Fungemia in cancer patients in Brazil: Predominance of non-albicans species
11. The changing face of candidemia: Emergence of non-Candida albicans species and antifungal resistance
12. Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogencic marrow transplant recipients: Long-term follow-up of a randomized, placebo-controlled trial
13. The effect of fluconazole prophylaxis on fungal colonization in neutropenic cancer patients
14. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole
15. Antimicrobial resistance in isolates for inpatients and outpatients in the United States: Increasing importance of the intensive care unit
16. Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital
17. Emerging evidence of selection of fluconazole-tolerant fungi in surgical intensive care units
18. Risk factors for candidemia in Neonatal Intensive Care Unit patients
19. Outbreak of Candida parapsilosis fungemia in neonatal intensive care units: Clinical implications and genotyping analysis
20. Candidemia in a neonatal intensive care unit: Trends during fifteen years and clinical features of 111 cases
21. Epidemiology of candidemia-A nationwide survey in Israel
22. Candidemia in allogeneic blood and marrow transplant recipients: Evolution of risk factors after the adoption of prophylactic fluconazole
23. Aspergillosis an increasing problem in tertiary care hospitals?
24. The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients with special attention to hepatic candidiasis
25. Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation
26. Infectious diseases in the liver transplant recipient
27. Development and validation of a prediction rule for invasive fungal infection in liver transplant recipients
28. Emerging trends in invasive mold infections in organ transplant recipients
29. Emergence of Candida parapsilosis s the predominant species causing candidemia in children
30. Nosocomial Candida guilliermondii fungemia in cancer patients
31. Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation
32. Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients
33. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia
34. Predictors of adverse outcome in cancer patients with candidemia
35. Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective observational study
36. Practice guidelines for the treatment of candidiasis
37. National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: Frequency of occurrence and antifungal susceptibility in the SCOPE program
38. American Society of Clinical Microbiology. American Society of Clinical Microbiology recommendations for the use of hematopoietic colony-stimulating factors: Evidence-based clinical practice guidelines
39. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation
40. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation - A prospective, randomized, double-blind study
41. Antifungal prophylaxis in organ transplant recipients: Seeking clarity amidst controversy
42. Intra-abdominal fungal infections after pancreatic transplantation: Incidence, treatment, and outcome
43. Ganciclovir/acyclovir and fluconazole prophylaxis after simultaneous kidney-pancreas transplantation
44. Studies of the mechanism of human salivary histatin-5 candidacidal activity with histatin-5 variants and azole sensitive- and resistant-Candida species
45. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance
46. Fungaemia survey: A 10-year experience in Bergamo, Italy
47. Longitudinal 10-year prospective survey of fungaemia in Slovak Republic: Trends in etiology in 310 episodes
48. Bloodstream infections due to Candida species: SENTRY Antimicrobial Surveillance Program in North America and Latin America, 1997-1998
49. Candidemia in cancer patients: A prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)